… body, or otherwise known as cancer.
“The acquisition of Turning Point Therapeutics … precision oncology asset,” Giovanni Caforio, M.D., board chair and chief … in a period of low merger and acquisitions in the biotechnology segment …
VIEW ARTICLE
If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.
